In healthy adults, the fall in pressure pain threshold over repeated measurements was smaller with intranasal oxytocin than with placebo, which means less first-hand pain sensitivity.
In plain wordsIn healthy adults, oxytocin nasal spray reduced the rise in pain sensitivity over repeated tests, compared with placebo.
- Peptide
- Oxytocin
- Outcome
- DecreaseFirst-hand pain sensitivity (pressure pain threshold decline over time)
- Study
n = 112
- Comparator
- Placebo
- Outcome group
- Pain · Nervous system and cognition
- Studied dose
- Dose not stated · intranasalAs given in this study (human).
Source sentences
Results showed that pressure pain thresholds decreased over time in both groups, indicating increased sensitivity to first-hand pain after repeated measurements. However, this decrease was smaller for participants who received intranasal oxytocin, indicative of oxytocin-induced attenuation of first-…
2 context sentences(design, population, supporting numbers)
Using a double-blind, placebo-controlled, between-participant experimental design, healthy participants (n = 112) were randomly assigned to either an intranasal oxytocin or placebo group.
Pain sensitivity was evaluated by pressure pain threshold, and empathetic responses were assessed by ratings in response to viewing video clips depicting others in physically painful scenarios.